11thestate
Nov 3, 12:27 PM
Investors can submit claims for the
$6.5M
$CODX settlement.
If you bought Co-Diagnostics (
$CODX) shares in 2022, you may have a chance to recover your losses. The settlement resolves claims that the company misled investors about demand for its Logix Smart™ COVID-19 Test, continuing to express confidence in demand despite declining sales.
The court has approved the settlement, and claims are now open. You can submit your claim for compensation: https://11th.com/cases/codiagnostics-investor-settlement
1 replies